Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,831,483 papers from all fields of science
Search
Sign In
Create Free Account
SD 3211
Known as:
SD-3211
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
sesamodil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model
Tomohiro Mori
,
Y. Ishigai
,
A. Fukuzawa
,
K. Chiba
,
T. Shibano
British Journal of Pharmacology
1995
Corpus ID: 25693546
1 The aim of the present study was to determine whether antianginal efficacy of semotiadil fumarate (SD‐3211), a structurally…
Expand
1995
1995
Effects of Semotiadil Fumarate (SD–3211) and Its Enantiomer, SD–3212, on the Changes in Cytosolic Ca2+ and Tension Caused by KC1 and Norepinephrine in Isolated Rat Aortas
Kazuyasu Murakami
,
K. Shindo
,
K. Ito
,
Katsuaki Ito
Journal of Cardiovascular Pharmacology
1995
Corpus ID: 26125394
Summary Semotiadil fumarate (SD–3211), a Ca2+ channel blocker of benzothiazine derivative and its (S)-(-)–enantiomer (SD–3212…
Expand
1994
1994
Effects of Ca2+ channel antagonists and their isomers on glibenclamide-sensitive K+ currents in follicle-enclosed Xenopus oocytes.
H. Sakuta
,
K. Okamoto
European Journal of Pharmacology
1994
Corpus ID: 4535812
1992
1992
Calcium Antagonistic and Binding Properties of Semotiadil (SD‐3211), a Benzothiazine Derivative Assessed in Cerebral and Coronary Arteries
K. Nakayama
,
K. Morimoto
,
Y. Nozawa
,
Y. Tanaka
Journal of Cardiovascular Pharmacology
1992
Corpus ID: 40979616
Summary: The present experiments were undertaken to elucidate Ca2+ antagonistic and binding properties of semotiadil and its (S…
Expand
1992
1992
Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and…
S. Nagashima
,
T. Uematsu
,
+4 authors
M. Nakashima
Naunyn-Schmiedeberg's Archives of Pharmacology
1992
Corpus ID: 10895354
SummaryAntiarrhythmic and electrophysiological effects of SD-3212, a novel antiarrhythmic agent, which has both Na+ channel and…
Expand
1991
1991
Antihypertensive Effect of a Novel Calcium Antagonist, SD‐3211, in Experimental Hypertensive Rats
T. Takada
,
N. Miyawaki
,
+4 authors
T. Iso
Journal of Cardiovascular Pharmacology
1991
Corpus ID: 32552206
The antihypertensive effect of SD-3211. a structurally novel type of nondihydropyridine calcium antagonist, was assessed using…
Expand
1991
1991
Antiarrhythmic effects of a novel Na+ and Ca++ channel blocker, SD‐3212: A comparison with its enantiomer (SD‐3211)
N. Miyawaki
,
Fumiko Yamazaki
,
T. Furuta
,
T. Shigei
,
H. Yamauchi
1991
Corpus ID: 85073814
The electrophysiological and antiarrhythmic effects of a structurally novel compound, SD‐3212, were evaluated in comparison with…
Expand
1991
1991
Cardiohemodynamic effect of a novel calcium antagonist, SD-3211, in the dog.
T. Takada
,
N. Miyawaki
,
+5 authors
T. Iso
Archives internationales de pharmacodynamie et de…
1991
Corpus ID: 36493388
The cardiohemodynamic effects of SD-3211, a calcium antagonist possessing a unique structure, were studied in anesthetized open…
Expand
1990
1990
Electrophysiological Properties of SD-3211, a Novel Putative Ca2+ Antagonist, in Isolated Guinea Pig and Rabbit Hearts
N. Miyawaki
,
T. Furuta
,
T. Shigei
,
H. Yamauchi
,
T. Iso
Journal of Cardiovascular Pharmacology
1990
Corpus ID: 36409902
Summary: The cardiac effects of SD-3211, a novel nondihydropyridine type of Ca2+ antagonist, were examined in isolated guinea pig…
Expand
1990
1990
Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
K. Nishimura
,
N. Miyawaki
,
H. Yamauchi
,
T. Iso
Arzneimittel-Forschung
1990
Corpus ID: 23773970
The effects of the novel Ca2+ antagonist sesamodil fumarate (JAN), (+)-3,4-dihydro-2-[5-methoxy-2-[3-[N-methyl-N-[2-[(3,4…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE